darunavir has been researched along with bms-626529 in 2 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (bms-626529) | Trials (bms-626529) | Recent Studies (post-2010) (bms-626529) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 28 | 3 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E; Liu, X; Pannecouque, C; Zhan, P | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for darunavir and bms-626529
| Article | Year |
|---|---|
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends.
Topics: Anti-HIV Agents; Chemistry, Pharmaceutical; Chemoprevention; Drug Design; Drug Discovery; Drug Resistance, Viral; HIV Protease Inhibitors; Humans; Molecular Targeted Therapy; Mutation; Prodrugs; Solubility; Structure-Activity Relationship | 2016 |
1 other study(ies) available for darunavir and bms-626529
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |